Brief: Cyclerion Updates On Timing Of Results Of Olinciguat Phase 2 Study In Sickle Cell Disease Patients

Korsana Biosciences

01/10/2020 12:52

Oct 1 (Reuters) - Cyclerion Therapeutics Inc  CYCN.O :
    * CYCLERION - UPDATE ON TIMING OF RESULTS OF OLINCIGUAT
PHASE 2
STRONG STUDY IN SICKLE CELL DISEASE PATIENTS & IW-6463
TRANSLATIONAL PHARMACOLOGY STUDY
    * CYCLERION - DUE TO COVID-19 RELATED OPERATIONAL DELAYS IN
OBTAINING CERTAIN STUDY DATA, CONTINUES TO PERFORM ANALYSES OF
DATA FROM BOTH STUDIES
    * CYCLERION THERAPEUTICS INC - EXPECTS TO COMMUNICATE TOP
LINE
RESULTS FROM BOTH THESE STUDIES IN THE COMING WEEKS

Source: [ID:https://bit.ly/30nMR9T]
Further company coverage:  CYCN.O 

 ((Reuters.Briefs@thomsonreuters.com;))